Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study

Combining ctDNA with tissue analysis, followed by sequential ctDNA assessments, effectively enhances the identification of actionable biomarkers. This strategy facilitates clinically beneficial, genetically informed therapies, underscoring its significant value in precision oncology.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2025-04-01
DOI
https://doi.org/10.1200/po.24.00283
Citations
2
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
1.87
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study

Kenichi Harano, Naoya Yamazaki, Chigusa Morizane, Hiroji Iwata et al.
2 citations
JCO Precision Oncology
Cancer Genomics and Diagnostics
1.87
article

Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study

Kenichi Harano, Naoya Yamazaki, Chigusa Morizane, Hiroji Iwata, Daisuke Aoki, Yu Sunakawa, Nobuaki Matsubara, Yoshiaki Nakamura, Satoshi Horasawa, Masafumi Ikeda, Hanna Tukachinsky, Takeshi Kato, Kentaro Yamazaki, Yasutoshi Sakamoto, Hideaki Bando, Geoffrey R. Oxnard, Hironaga Satake, Kenjiro Namikawa, Tomoyuki Otsuka, Makoto Ueno, Shigenori Kadowaki, Takao Fujisawa, Tadamichi Denda, Yoshito Komatsu, Hikaru Abutani, Taito Esaki, Taroh Satoh, Nobuhisa Matsuhashi, Takayuki Yoshino, Eiji Oki, Yoichi Naito, Tetsuya Hamaguchi, Naomi Kuramoto, Hisateru Yasui, Hiroya Taniguchi, Naoki Takahashi, Susumu Okano, Ken Kato, Norio Nonomura, Tomohiro Nishina, Jessica Lee, Masahiro Goto
article en
2 citations

Abstract

Combining ctDNA with tissue analysis, followed by sequential ctDNA assessments, effectively enhances the identification of actionable biomarkers. This strategy facilitates clinically beneficial, genetically informed therapies, underscoring its significant value in precision oncology.

JCO Precision OncologyVol. 9(9)
Kansai Medical University (JP), Kyushu University (JP), St. Marianna University School of Medicine (JP), Keio University (JP), Boston Foundation (US), Kanagawa Prefectural Hospital Organization (JP), Juntendo University (JP), Shizuoka Cancer Center (JP), Kochi Medical School Hospital (JP), Osaka National Hospital (JP), National Hospital Organization Kyushu Cancer Center (JP), Chiba Cancer Center (JP), Saitama Cancer Center (JP), Aichi Cancer Center (JP), Shikoku Cancer Center (JP), Hokkaido University Hospital (JP), National Cancer Center Hospital East (JP), Osaka International Cancer Institute (JP), Osaka University Hospital (JP), Kobe City Medical Center General Hospital (JP), Gifu University (JP), Kanagawa Cancer Center, Foundation Medicine (United States), Saitama Medical University (JP), Osaka University of Pharmaceutical Sciences (JP), The University of Osaka (JP)
Good health and well-being
Openalex Percentile: Top 15%
Cancer Genomics and Diagnostics
1.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.